Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 245.55
-1.25 (-0.51%)
Oct 6, 2026, 4:59 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.09 trillion as of October 6, 2026. Its market cap has decreased by -35.16% in one year.
Market Cap
1.09T
Enterprise Value
1.19T
Revenue
329.43B
Ranking
n/a
PE Ratio
9.42
Stock Price
245.55
ChartMarket Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.09T, an increase of 2,272.84%. That is a compound annual growth rate of 11.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 1.09T | -24.47% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genmab | 142.04B |
| Coloplast | 92.32B |
| Demant | 67.32B |
| ALK-Abelló | 44.91B |
| H. Lundbeck | 43.46B |
| Zealand Pharma | 18.09B |
| Ambu A/S | 17.80B |
| Bavarian Nordic | 16.84B |